Acurx Stock Financials

ACXP
 Stock
  

USD 2.92  0.01  0.34%   

We suggest to use analysis of Acurx Pharmaceuticals fundamentals to see if markets are presently mispricing the company. We have analyzed and interpolated twenty-one available fundamental indicators for Acurx Pharmaceuticals, which can be compared to its rivals. To ensure the equity is not overpriced, please confirm all Acurx Pharmaceuticals financials, including its price to book, debt to equity, as well as the relationship between the Debt to Equity and earnings per share . Please also double-check Acurx Pharmaceuticals cash per share to validate the company can sustain itself down the road. Use Acurx Pharmaceuticals to protect your portfolios against small market fluctuations. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a normal downward trend and little activity. Check odds of Acurx Pharmaceuticals to be traded at $2.89 in 90 days.
  
With this module, you can analyze Acurx financials for your investing period. You should be able to track the changes in Acurx Pharmaceuticals individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

Acurx Most Recent Estimates

Diluted Eps
(1.49) 
EPS Estimate Current Year
(1.14) 
EPS Estimate Next Year
(0.96) 
EPS Estimate Current Quarter
(0.35) 
Earnings Share
(1.49) 
Understanding current and past Acurx Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Acurx Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Acurx Pharmaceuticals' assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Over 75
Acurx Pharmaceuticals has more than 75 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Acurx Pharmaceuticals stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Acurx Pharmaceuticals' official financial statements usually reflect Acurx Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Acurx Pharmaceuticals. For example, before you start analyzing numbers published by Acurx accountants, it's critical to develop an understanding of what Acurx Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Acurx Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Acurx Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Acurx Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Acurx Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Acurx Pharmaceuticals' management to manipulate its earnings.

Acurx Pharmaceuticals Company Summary

Acurx Pharmaceuticals competes with Regeneron Pharmaceuticals, and Vertex Pharmaceutic. Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is based in Staten Island, New York. Acurx Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
Business Address259 Liberty Avenue
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.acurxpharma.com
Phone917 533 1469
CurrencyUSD - US Dollar

Acurx Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Acurx Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Acurx Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Acurx Pharmaceuticals competition to find correlations between indicators driving Acurx Pharmaceuticals's intrinsic value. More Info.
Acurx Pharmaceuticals is rated third in cash per share category among related companies. It is number one stock in current ratio category among related companies fabricating about  24.29  of Current Ratio per Cash per Share. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Acurx Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Acurx Pharmaceuticals' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Acurx Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Acurx Pharmaceuticals Systematic Risk

Acurx Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Acurx Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Acurx Pharmaceuticals correlated with the market. If Beta is less than 0 Acurx Pharmaceuticals generally moves in the opposite direction as compared to the market. If Acurx Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Acurx Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Acurx Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Acurx Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
.

About Acurx Pharmaceuticals Financials

What exactly are Acurx Pharmaceuticals Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Acurx Pharmaceuticals' income statement, its balance sheet, and the statement of cash flows. Potential Acurx Pharmaceuticals investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Acurx Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Acurx Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Acurx Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Acurx Pharmaceuticals is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Acurx has grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Acurx Pharmaceuticals November 27, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Acurx Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Acurx Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Acurx Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Acurx Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Acurx Pharmaceuticals's daily price indicators and compare them against related drivers.
Information Ratio(0.07)
Maximum Drawdown22.04
Value At Risk(7.72)
Potential Upside7.92
Please continue to Trending Equities. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for analysis

When running Acurx Pharmaceuticals price analysis, check to measure Acurx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acurx Pharmaceuticals is operating at the current time. Most of Acurx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acurx Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Acurx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acurx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Is Acurx Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acurx Pharmaceuticals. If investors know Acurx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acurx Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
35.6 M
Return On Assets
(0.55) 
Return On Equity
(0.95) 
The market value of Acurx Pharmaceuticals is measured differently than its book value, which is the value of Acurx that is recorded on the company's balance sheet. Investors also form their own opinion of Acurx Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Acurx Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acurx Pharmaceuticals' market value can be influenced by many factors that don't directly affect Acurx Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acurx Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Acurx Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acurx Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.